Denis Crevat

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines

Rosario Z. Capeding, Imelda Luna, Emily Bomasang et al. · Vaccine · 2011 · 126 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +14

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years

Yee‐Sin Leo, Annelies Wilder‐Smith, Sophia Archuleta et al. · Human Vaccines & Immunotherapeutics · 2012 · 91 citations · Full text

Medicine, Immunology, Pediatrics +15

Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru

Claudio F. Lanata, Teresa Andrade, Ana Izquierdo Gil et al. · Vaccine · 2012 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore

Anke Harenberg, Sarah Begue, Audrey Mamessier et al. · Human Vaccines & Immunotherapeutics · 2013 · 50 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study

Amar–Singh HSS, Mia-Tuang Koh, Kah Kee Tan et al. · Vaccine · 2013 · 49 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17